Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 2 | 2 | 2 | 64 |
| Accounts receivable | -88 | -16 | -14 | -2 | -22 |
| Other Working Capital | -195 | 105 | -1 | -212 | 64 |
| Other Operating Activity | 95 | -402 | -275 | -330 | -696 |
| Operating Cash Flow | $-188 | $-312 | $-287 | $-542 | $-589 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | 20 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | N/A | N/A | 27 |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $27 |
| Beginning Cash Position | 1,599 | 1,822 | 2,161 | 2,703 | 3,138 |
| End Cash Position | 1,382 | 1,599 | 1,822 | 2,161 | 2,641 |
| Net Cash Flow | $-188 | $-312 | $-287 | $-542 | $-542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -188 | -312 | -287 | -542 | -589 |
| Free Cash Flow | -188 | -312 | -287 | -542 | -589 |